KPTI — KARYOPHARM THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 105 家机构在其最新 13F 申报中持有 KPTI(KARYOPHARM THERAPEUTICS INC),合计申报市值 $209.78M,对应 21.50M 股。按股数计算较上季度增持 26.2%(+3.77M 股),申报市值环比上升 121.2%。持仓集中度较高:前五大持有人占申报市值的 36.3%,前十大的集中度为 56.4%。
与上一季度相比,35 家新建仓位、34 家加仓、18 家减仓、18 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
KARYOPHARM THERAPEUTICS INC(KPTI)的主要机构持有人包括 Opti Capital Management, LP、RA CAPITAL MANAGEMENT, L.P.、HIGHBRIDGE CAPITAL MANAGEMENT LLC,按 13F 申报市值在本页 249 家持有人中排名居前。
KPTI 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 58 | 7.14M | $8.71M | +30.0% |
| Q2 2026 | 105 | 21.50M | $209.78M | +26.2% |
| Q1 2026 | 88 | 19.05M | $106.05M | +54.2% |
| Q4 2025 | 68 | 9.41M | $69.20M | -91.3% |
| Q3 2025 | 63 | 111.39M | $106.27M | -2.1% |
| Q2 2025 | 60 | 114.31M | $103.22M | -54.6% |
| Q1 2025 | 56 | 26.78M | $30.57M | -62.7% |
| Q4 2024 | 87 | 78.40M | $139.62M | +4.5% |
表内 8 个季度中,机构持股合计减少 91%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(-91.3%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.52M | $1.86M | 0.00% | 增持 | |
| 963.89K | $1.18M | 0.00% | 增持 | |
| 940.81K | $1.15M | 0.00% | 减持 | |
| 542.50K | $661.85K | 0.00% | 新进 | |
| 458.52K | $559.56K | 0.00% | 减持 | |
| 385.75K | $470.61K | 0.00% | 增持 | |
| 369.34K | $450.60K | 0.00% | 增持 | |
| 263.70K | $321.71K | 0.01% | 新进 | |
| 250.61K | $301.99K | 0.00% | 增持 | |
| 240.31K | $293.18K | 0.00% | 增持 | |
| 136.52K | $166.56K | 0.00% | 增持 | |
| 135.90K | $165.80K | 0.00% | 增持 | |
| 114.07K | $139.16K | 0.00% | 减持 | |
| 87.09K | $106.25K | 0.00% | 增持 | |
| 81.10K | $98.94K | 0.00% | 新进 | |
| 73.61K | $89.80K | 0.00% | 减持 | |
| 71.84K | $87.64K | 0.05% | 新进 | |
| 65.58K | $80.00K | 0.00% | 增持 | |
| 57.26K | $69.86K | 0.00% | 持有 | |
| 47.19K | $57.57K | 0.00% | 增持 | |
| 39.40K | $48.07K | 0.00% | 减持 | |
| 38.23K | $46.64K | 0.01% | 新进 | |
| 36.00K | $43.38K | 0.00% | 增持 | |
| 31.50K | $38.43K | 0.00% | 增持 | |
| 30.77K | $37.53K | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.49M | $10.98M | 0.01% | 增持 | |
| 930.00K | $6.84M | 0.90% | 减持 | |
| 889.58K | $6.55M | 0.40% | 增持 | |
| 559.62K | $4.12M | 0.00% | 增持 | |
| 544.55K | $4.01M | 0.46% | 增持 | |
| 440.00K | $3.24M | 0.12% | 新进 | |
| 421.32K | $3.10M | 0.01% | 持有 | |
| 310.02K | $2.28M | 0.03% | 减持 | |
| 303.37K | $2.23M | 0.08% | 减持 | |
| 295.54K | $2.18M | 1.09% | 增持 | |
| 276.88K | $2.04M | 0.00% | 新进 | |
| 252.54K | $1.86M | 0.41% | 新进 | |
| 247.56K | $1.82M | 0.00% | 增持 | |
| 187.73K | $1.38M | 0.00% | 增持 | |
| 148.79K | $1.10M | 0.00% | 新进 | |
| 147.70K | $1.09M | 0.00% | 增持 | |
| 144.63K | $1.06M | 0.03% | 新进 | |
| 142.98K | $1.05M | 0.19% | 持有 | |
| 134.57K | $990.41K | 0.29% | 持有 | |
| 128.45K | $945.40K | 0.00% | 持有 | |
| 100.00K | $736.00K | 0.01% | 持有 | |
| 95.67K | $704.15K | 0.01% | 新进 | |
| 89.73K | $660.40K | 0.00% | 新进 | |
| 88.45K | $651.03K | 0.00% | 增持 | |
| 78.50K | $577.76K | 0.01% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 48.48M | $34.96M | 1.10% | 持有 | |
| 30.00M | $20.88M | 0.33% | 持有 | |
| 23.62M | $17.72M | 0.97% | 持有 | |
| 8.87K | $6.40M | 0.25% | 持有 | |
| 6.00M | $4.63M | 0.66% | 持有 | |
| 700.99K | $4.58M | 0.00% | 减持 | |
| 421.32K | $2.76M | 0.00% | 持有 | |
| 408.22K | $2.67M | 0.00% | 减持 | |
| 231.95K | $1.52M | 0.00% | 减持 | |
| 157.60K | $1.03M | 0.10% | 持有 | |
| 142.98K | $935.12K | 0.17% | 减持 | |
| 134.57K | $880.06K | 0.20% | 持有 | |
| 128.45K | $840.07K | 0.00% | 持有 | |
| 1.15K | $754.06K | 0.00% | 新进 | |
| 100.00K | $654.00K | 0.01% | 持有 | |
| 93.29K | $610.25K | 0.00% | 增持 | |
| 64.71K | $423.23K | 0.00% | 减持 | |
| 59.69K | $390.34K | 0.00% | 减持 | |
| 48.10K | $314.57K | 0.22% | 减持 | |
| 46.34K | $303.08K | 0.00% | 增持 | |
| 45.70K | $298.88K | 0.00% | 增持 | |
| 40.00K | $261.60K | 0.04% | 减持 | |
| 35.34K | $231.12K | 0.00% | 增持 | |
| 34.87K | $228.07K | 0.01% | 减持 | |
| 33.80K | $221.05K | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 48.48M | $35.54M | 1.40% | 新进 | |
| 30.00M | $21.24M | 0.35% | 新进 | |
| 23.62M | $17.72M | 1.05% | 新进 | |
| 8.87K | $5.02M | 0.24% | 新进 | |
| 6.00M | $4.56M | 0.93% | 持有 | |
| 728.77K | $3.14M | 0.00% | 增持 | |
| 518.27K | $2.23M | 0.00% | 增持 | |
| 421.32K | $1.82M | 0.00% | 持有 | |
| 2.00M | $1.52M | 1.25% | 持有 | |
| 257.15K | $1.11M | 0.10% | 持有 | |
| 236.64K | $1.02M | 0.00% | 减持 | |
| 187.91K | $809.90K | 0.17% | 减持 | |
| 168.53K | $726.38K | 0.00% | 增持 | |
| 161.90K | $697.79K | 0.00% | 增持 | |
| 157.50K | $678.83K | 0.10% | 减持 | |
| 146.01K | $629.32K | 0.13% | 减持 | |
| 134.57K | $579.98K | 0.12% | 持有 | |
| 128.45K | $553.62K | 0.00% | 持有 | |
| 109.40K | $471.53K | 0.00% | 增持 | |
| 100.00K | $431.00K | 0.01% | 持有 | |
| 91.84K | $395.92K | 0.00% | 减持 | |
| 70.00K | $301.70K | 0.06% | 增持 | |
| 65.81K | $283.66K | 0.00% | 增持 | |
| 37.84K | $163.07K | 0.00% | 新进 | |
| 33.30K | $143.50K | 0.00% | 增持 |
新建仓(Q2 2026)
- Kalehua Capital Management LLC 685.64K 股 · $6.70M
- NEA Management Company, LLC 576.78K 股 · $5.64M
- GEODE CAPITAL MANAGEMENT, LLC 531.23K 股 · $5.19M
- Ghisallo Capital Management LLC 500.00K 股 · $4.88M
- SILVERARC CAPITAL MANAGEMENT, LLC 297.46K 股 · $2.91M
- VANGUARD PORTFOLIO MANAGEMENT LLC 134.82K 股 · $1.32M
- DLD Asset Management, LP 80.10K 股 · $780.98K
- J. Goldman & Co LP 67.50K 股 · $659.48K
- Squarepoint Ops LLC 63.80K 股 · $623.34K
- Sixth Street Partners Management Company, L.P. 61.94K 股 · $605.18K
- Nuveen, LLC 37.87K 股 · $369.97K
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 33.33K 股 · $326.00K
完全清仓(较上季)
- Commodore Capital LP 卖出 1.95M 股 · $10.86M
- Squadron Capital Management LLC 卖出 750.00K 股 · $4.18M
- Ikarian Capital, LLC 卖出 733.43K 股 · $4.09M
- Ally Bridge Group (NY) LLC 卖出 250.00K 股 · $1.39M
- DIADEMA PARTNERS LP 卖出 241.30K 股 · $1.34M
- BOOTHBAY FUND MANAGEMENT, LLC 卖出 213.81K 股 · $1.19M
- ADAR1 Capital Management, LLC 卖出 136.74K 股 · $761.62K
- STATE STREET CORP 卖出 80.74K 股 · $449.73K
- Balyasny Asset Management 卖出 70.75K 股 · $394.07K
- HRT FINANCIAL LP 卖出 70.00K 股 · $389.00K
- DAFNA Capital Management LLC 卖出 45.80K 股 · $255.11K
- Zimmer Partners, LP 卖出 37.50K 股 · $208.88K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 1.52M | 1.42M | 244.90K | 247.56K | 231.95K | 236.64K | 242.74K | 3.77M | 3.64M | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 963.89K | 353.55K | 194.02K | 88.45K | 59.69K | 161.90K | 93.61K | 145.79K | 134.48K | 140.68K | 254.93K | 457.19K | 906.64K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 940.81K | 958.98K | 739.75K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STRS OHIO | 542.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 458.52K | 531.23K | 206.13K | 187.73K | 93.29K | 91.84K | 99.64K | 1.39M | 1.36M | 1.31M | 2.52M | 2.38M | 2.29M | — | — | 1.38M | — | — | — | — |
| Morgan Stanley | 385.75K | 202.51K | 18.57K | 8.86K | 25.77K | 25.09K | 10.42K | 3.51M | 123.65K | 200.01K | 294.79K | 845.15K | 1.04M | — | — | — | — | — | — | — |
| STATE STREET CORP | 369.34K | — | 80.74K | 58.94K | 46.34K | 33.30K | 29.50K | 442.51K | 409.51K | 453.81K | 2.29M | 2.05M | 2.04M | — | — | — | — | — | — | — |
| Context Capital Management, LLC | 263.70K | — | — | 62.99K | 8.87K | 8.87K | — | — | 8.87K | — | 21.49K | 21.49M | 21.49K | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 250.61K | 6.30K | 471 | 1.74K | 550 | 38.00K | 38.00K | 38.00K | 38.00K | 38.00K | 38.00K | 38.00K | 38.00K | 38.00K | 38.00K | 1.48M | — | 900.00K | 129.30K | 5.29M |
| Fidelity Management & Research (FMR) | 240.31K | 8.94K | 665 | 679 | 679 | 765 | 527 | 412.46K | 369.72K | 293.21K | 273.81K | 268.29K | 266.45K | — | — | — | — | — | — | — |
| Invesco Ltd | 136.52K | 90.30K | 16.74K | — | — | — | — | — | 58.15K | 40.51K | 27.97K | 28.47K | 63.81K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 135.90K | 134.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 114.07K | 145.40K | 114.93K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Quadrature Capital Ltd | 87.09K | 10.30K | — | 59.71K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PANAGORA ASSET MANAGEMENT INC | 81.10K | — | — | — | — | — | — | — | — | — | 229.92K | 227.44K | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 73.61K | 188.04K | 84 | 82 | 82 | 29.64K | 28.96K | 1.31M | 1.98M | 2.27M | 1.77M | 1.77M | 1.66M | — | — | — | — | — | — | — |
| BML Capital Management, LLC | 71.84K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 65.58K | 37.87K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 57.26K | 57.26K | 11.40K | 11.09K | 11.09K | 11.09K | 11.09K | 166.32K | 166.32K | 166.31K | 487.06K | 497.20K | 653.65K | — | — | — | — | — | — | — |
| Citigroup Inc | 47.19K | 37.92K | 4.94K | 1 | 513 | 7.04K | 7.04K | 105.68K | 105.69K | 162.03K | 18.92K | 16.43K | 1.60K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold KPTI?
As of 2026-Q2, 105 institutional funds reported holding KPTI (KARYOPHARM THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $209.78M.
How many shares of KPTI do institutions own?
13F filers reported 21.50M shares of KPTI, worth $209.78M in aggregate at the end of 2026-Q2.
Is institutional ownership of KPTI rising or falling?
Share counts moved +26.2% versus the prior quarter — accumulation.
Who are the top institutional holders of KPTI?
The largest 13F holders are Opti Capital Management, LP, RA CAPITAL MANAGEMENT, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., ACORN CAPITAL ADVISORS, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of KARYOPHARM THERAPEUTICS INC?
The major shareholders of KARYOPHARM THERAPEUTICS INC (KPTI) by reported 13F value are Opti Capital Management, LP, RA CAPITAL MANAGEMENT, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., ACORN CAPITAL ADVISORS, LLC, among 249 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.